CompletedNot Applicable

Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves.

Canada30 participantsStarted 2018-11-09

Plain-language summary

Therefore, the objective of the study is to characterize the pattern of radiolabeled tracer (18F-FDG) uptake in noninfected transcatheter heart valves in early follow-up after transcatheter aortic valve replacement (TAVR).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients \>18-year-old undergoing TAVR procedure with Edwards Sapien 3 and Core Valve Evolut R devices. * Informed written consent Exclusion Criteria: * Inability to provide signed informed consent. * Patients with definitive or possible IE according to modified Duke criteria and current clinical guidelines for the management of IE. * Any contraindication for 18F-FDG PET/CT. * Any condition making it unlikely the patient will be able to complete the protocol procedures and follow-up visits.

What they're measuring

Radiolabeled tracer uptake grade (intense, moderate, mild or absent) in the prosthetic and periprosthetic areas.

Timeframe: 3 months after TAVR

Trial details

NCT IDNCT03683355

SponsorCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-01

View on ClinicalTrials.gov More Infective Endocarditis trials